Koller, Dominik P.
Kasanin, Vida http://orcid.org/0000-0002-1817-7782
Flynn-Evans, Erin E.
Sullivan, Jason P.
Dijk, Derk-Jan
Czeisler, Charles A. http://orcid.org/0000-0002-7408-1849
Barger, Laura K. http://orcid.org/0000-0001-8547-7331
Funding for this research was provided by:
European Space Agency
Article History
Received: 4 January 2021
Accepted: 7 October 2021
First Online: 18 November 2021
Competing interests
: D.P.K., V.K., E.E.F.-E., and J.P.S. declare no competing interests. Dr. Barger is on the scientific advisory board for CurAegis Technologies. She has received consulting fees from the University of Pittsburgh, Sygma, Insight, and Puget Sound Pilots. Dr. Czeisler reports that he was a paid consultant to Bose, Boston Celtics, Boston Red Sox, Cephalon, Institute of Digital Media and Child Development, Jazz Pharma, Merck, Purdue Pharma, Samsung, Teva, and Vanda Pharmaceuticals, where he also holds an equity interest. C.A.C. receives or has received research/education support from Cephalon, Mary Ann & Stanley Snider via Combined Jewish Philanthropies, NFL Charities, Jazz Pharma, Optum, ResMed, San Francisco Bar Pilots, Sanofi, Schneider, Simmons, Sysco, Philips, Vanda Pharmaceuticals, Dayzz Ltd, Teva Pharma Australia PTY Ltd. In addition, since 1985, C.A.C. has served as an expert witness in a number of legal cases, including those involving Amtrak, Bombardier, C&J Energy, Casper Sleep, Inc., Columbia River Bar Pilots, Dallas Police Association, Enterprise Rent-A-Car, Fedex, Greyhound, Purdue Pharma, UPS, and Vanda Pharmaceuticals. C.A.C. serves as the incumbent of a professorship endowed by Cephalon, and receives royalties from McGraw Hill, and from Philips Respironics (for the Actiwatch-2 & Actiwatch Spectrum devices). C.A. Czeisler’s interests were reviewed and managed by Brigham and Women’s Hospital and Partners HealthCare in accordance with their conflict of interest policies. Dr Dijk reports that he was a paid consultant to F. Hoffmann- La Roche Ltd, Pfizer Inc, Eli Lilly and Company, Novo Nordisk A/S, Ono Pharma UK Ltd and has received research support from Janssen Research & Development LLC, Eli Lilly and Company, and GW Pharma.